India Organ Preservation Market Overview
The India Organ Preservation Market is expanding as demand for organ transplantation increases and healthcare providers adopt advanced preservation technologies. Technological advancements in organ preservation, growing government support for organ donation, improving healthcare infrastructure, and increasing investment by private healthcare providers are supporting market development in India.
According to the Market Research Future report updated August 24, 2026, the India Organ Preservation Market was valued at USD 21.1 Million in 2024 and is projected to grow from USD 22.09 Million in 2025 to USD 35 Million by 2035, registering a CAGR of 4.71% during 2025–2035. Citrate Solution represents the largest solution segment, Perfadex is the fastest-growing solution, Dynamic Cold Storage leads preservation techniques, Kidney is the largest organ type, and Hospitals & Clinics account for the largest end-user segment.
Unlock Exclusive Insights – Request Your Free Sample Report Now!
https://www.marketresearchfuture.com/sample_request/49456
Key players driving innovation and competitiveness in the India Organ Preservation Market include:
Organ Recovery Systems
TransMedics
Xvivo Perfusion
LifeLink Foundation
Tissue Regenix
Baxter International
Medtronic
NantKwest
The market is being shaped by rising demand for organ transplants, advances in preservation techniques, increasing awareness of organ donation, and stronger government support. Hypothermic machine perfusion, normothermic perfusion, advanced preservation solutions, and improved organ-storage technologies are helping extend organ viability and address logistical challenges associated with transplantation.
The India Organ Preservation Market can be segmented by Solution into University of Wisconsin Solution, Custodial HTK, Collins Solution, Celsior Solution, Perfadex, and Citrate Solution. By Preservation Techniques, it includes Static Cold Storage and Dynamic Cold Storage. By Organ Type, it covers Kidney, Liver, Heart, and Lungs. By End User, it includes Hospitals & Clinics and Organ Banks.
The growing need for effective organ transplantation is creating opportunities for organ-preservation technology providers, hospitals, transplant centers, organ banks, medical-device companies, and healthcare organizations. Advanced machine perfusion systems, specialized preservation solutions, biobanking facilities, improved transportation technologies, and partnerships between hospitals and technology providers can support future market expansion.
Recent Developments and Market Trends:
Citrate Solution remains the largest solution segment because of its established use, preservation capabilities, and acceptance among healthcare institutions and transplantation centers.
Perfadex is the fastest-growing solution segment as technological developments and increasing awareness of its preservation capabilities support adoption, particularly for organs such as lungs and livers.
Dynamic Cold Storage represents the largest preservation technique because of its temperature-control capabilities and adoption across major healthcare institutions.
Static Cold Storage is gaining traction because of its comparatively simple operation and lower costs, creating opportunities among smaller healthcare facilities.
Kidney preservation represents the largest organ-type segment, supported by the high demand for kidney transplantation and the prevalence of kidney-related diseases.
Liver preservation is emerging as a fast-growing segment as liver-related health conditions increase and innovative preservation technologies improve access to transplantation.
Hospitals & Clinics account for the largest end-user segment because they have established transplant infrastructure and provide comprehensive organ-preservation and transplantation services.
Organ Banks are expanding as organ donation programs, public awareness, and preservation technologies improve. Their role in organ collection, storage, and distribution is becoming increasingly important.
Technological advancements in machine perfusion and advanced preservation solutions are improving the ability to maintain organ viability during storage and transportation.
Hypothermic machine perfusion and normothermic perfusion are gaining attention because they can help extend preservation periods and address logistical challenges that can delay transplantation in India.
Government initiatives supporting organ donation and transplantation are creating a more favorable environment for organ-preservation technologies. The National Organ and Tissue Transplant Organization (NOTTO) is also contributing to coordination and infrastructure development for organ donation activities.
Increasing public awareness and education about organ donation are supporting the availability of organs for transplantation and, consequently, the need for effective preservation solutions.
Private healthcare providers are increasing investment in advanced preservation technologies, particularly in metropolitan areas where demand for transplantation services is high.
Improving healthcare infrastructure is expanding access to advanced organ-preservation technologies and specialized transplantation services across India.
Sustainability is becoming an emerging consideration in organ preservation, with increasing attention to reducing waste, improving storage efficiency, and developing more environmentally responsible preservation solutions.
Digitalization and artificial intelligence are increasingly influencing the competitive landscape, creating opportunities for smarter monitoring, data-driven preservation processes, and improved operational efficiency.
Strategic partnerships between technology companies and hospitals are helping expand access to advanced preservation systems and support the localization of organ-preservation technologies in India.
Recent industry activity highlighted by MRFR includes an October strategic partnership between Xvivo Perfusion and an Indian hospital network, Baxter International’s September launch of a new line of organ-preservation solutions tailored to the Indian market, and LifeLink Foundation’s August expansion through a regional office in India.
MRFR also highlights developments involving Otsuka Pharmaceutical, Organ Transport Systems, Collective Health, CryoLife, and Organ Recovery Systems, reflecting continued investment in organ-storage methodologies, preservation technologies, and transplantation infrastructure.
Reasons to Buy the Report:
Provides comprehensive insights into the India Organ Preservation Market dynamics, trends, opportunities, and growth potential.
Helps identify opportunities across preservation solutions, machine-based techniques, organ types, and end-user segments.
Offers detailed segmentation analysis across solution, preservation technique, organ type, and end-user markets.
Includes competitive intelligence covering leading organ-preservation, medical-device, and healthcare companies.
Supports informed decisions using market forecasts, organ-transplant demand, technological advancements, government initiatives, healthcare infrastructure development, and emerging opportunities.
Future Outlook:
The future of the India Organ Preservation Market will be shaped by increasing demand for organ transplantation, technological advancements, government support, private-sector investment, and improvements in healthcare infrastructure. Market Research Future projects the market to reach USD 35 Million by 2035 at a CAGR of 4.71% during 2025–2035.
Citrate Solution should continue to represent the largest solution segment, while Perfadex is positioned for strong growth as advanced preservation technologies gain adoption. Dynamic Cold Storage should remain the leading preservation technique, while Static Cold Storage can expand among facilities seeking simpler and more cost-effective preservation methods.
Kidney should remain the largest organ-type segment, while Liver preservation is expected to gain traction as liver transplantation demand and preservation capabilities increase. Hospitals & Clinics should continue to represent the largest end-user segment, while Organ Banks are expected to expand as organ donation programs and preservation infrastructure develop.
Machine perfusion, advanced preservation solutions, biobanking, AI-supported monitoring, sustainable preservation practices, improved organ transportation, and strategic partnerships between hospitals and technology providers are expected to influence the next phase of market development in India.
➤➤Explore Our Latest Related Reports:
